Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / closing-certificate-veridian.docx
closing-certificate-veridian.docx
High · 0
Medium · 0
Standard · 0
1. Penterra Pharmaceuticals Corp.
1. Penterra Pharmaceuticals Corp. Attn: Nathaniel Briggs, Esq. Vice President & General Counsel 200 Biopharma Boulevard, Suite 1400 Princeton, NJ 08540 Telephone: (609) 555-4100 Email: n.briggs@penterrapharma.com
2. Calderwood & Harkness LLP
2. Calderwood & Harkness LLP Attn: Miriam Calloway, Partner 280 Park Avenue, 34th Floor New York, NY 10017 Telephone: (212) 555-7300 Email: m.calloway@calderwoodharkness.com
3. Veridian Health Research Network, Inc. (Internal Copy)
3. Veridian Health Research Network, Inc. (Internal Copy) Attn: Gregory Callahan, Esq. Vice President, Legal & Compliance 750 Research Parkway, 8th Floor Philadelphia, PA 19104 Telephone: (215) 555-8215 Email: g.callahan@veridianhealthresearch.org
4. Whitmore, Jansen & Callahan LLP
4. Whitmore, Jansen & Callahan LLP Attn: Allison Whitmore, Partner 1500 Market Street, Suite 3200 Philadelphia, PA 19102 Telephone: (215) 555-6600 Email: a.whitmore@wjclaw.com This Closing Certificate and the certifications, representations, and statements contained herein are subject to the terms and conditions of the Master Clinical Trial Agreement dated June 28, 2023, between Penterra Pharmaceuticals Corp. and Ver